Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta Sells 46,857 Shares

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 46,857 shares of Cardlytics stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the completion of the sale, the chief executive officer now owns 418,637 shares of the company’s stock, valued at $1,423,365.80. This trade represents a 10.07 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Amit Gupta also recently made the following trade(s):

• On Friday, January 24th, Amit Gupta sold 15,160 shares of Cardlytics stock. The stock was sold at an average price of $3.92, for a total transaction of $59,427.20.
• On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total value of $21,887.88.

Cardlytics Trading Down 7.4 %

Shares of CDLX stock opened at $3.12 on Thursday. Cardlytics, Inc. has a fifty-two week low of $2.76 and a fifty-two week high of $20.52. The stock’s fifty day moving average price is $3.45 and its two-hundred day moving average price is $3.72. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. The company has a market cap of $158.56 million, a PE ratio of -0.51 and a beta of 1.54.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Mirabella Financial Services LLP acquired a new stake in shares of Cardlytics in the 4th quarter valued at approximately $4,285,000. D. E. Shaw & Co. Inc. boosted its position in Cardlytics by 97.4% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,131,505 shares of the company’s stock valued at $4,198,000 after buying an additional 558,235 shares in the last quarter. RBF Capital LLC boosted its position in Cardlytics by 311.9% in the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock valued at $1,562,000 after buying an additional 369,620 shares in the last quarter. GSA Capital Partners LLP grew its stake in shares of Cardlytics by 1,273.2% during the third quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock worth $1,223,000 after buying an additional 354,474 shares during the last quarter. Finally, Rangeley Capital LLC acquired a new position in shares of Cardlytics during the fourth quarter worth $1,187,000. Institutional investors own 68.10% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on CDLX shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $6.92.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.